IBT
International Biotechnology Trust Portfolio holdings
AUM
$297M
1-Year Return
17.25%
This Quarter Return
-18.72%
1 Year Return
+17.25%
3 Year Return
+11.14%
5 Year Return
+79.35%
10 Year Return
–
AUM
$161M
AUM Growth
-$49.3M
(-23%)
Cap. Flow
-$15.6M
Cap. Flow
% of AUM
-9.66%
Top 10 Holdings %
Top 10 Hldgs %
56.91%
Holding
57
New
6
Increased
7
Reduced
18
Closed
12
Top Buys
| 1 |
Gilead Sciences
GILD
|
$6.04M |
| 2 |
Neurocrine Biosciences
NBIX
|
$5.06M |
| 3 |
Biogen
BIIB
|
$4.06M |
| 4 |
Amgen
AMGN
|
$3.67M |
| 5 |
RDUS
Radius Health, Inc.
RDUS
|
$3.18M |
Top Sells
| 1 |
ARRY
Array Biopharma Inc
ARRY
|
$8.64M |
| 2 |
ADMS
Adamas Pharmaceuticals, Inc.
ADMS
|
$5.67M |
| 3 |
Puma Biotechnology
PBYI
|
$5.07M |
| 4 |
Illumina
ILMN
|
$4.24M |
| 5 |
SPPI
Spectrum Pharmaceuticals Inc
SPPI
|
$3.86M |
Sector Composition
| 1 | Healthcare | 95.84% |